Question: who increased the price of insulin?
Answer: In 2017, Lilly sold $1.7 billion worth of the drug. The increased revenue in Lilly's coffers was due largely to price increases, a fact Lilly admits over and over in its own annual reports to shareholders. Today, there is just one copycat version of insulin — and it is manufactured by Eli Lilly.